You Are Currently Here! > Home > Company News

Aminowill Shines at CPHI Japan 2024, Showcasing Advanced Amino Acid Solutions

Article source:April 24, 2024vide

Aminowill, a renowned brand under Wuxi Jinghai Amino Acid Co., Ltd., successfully participated in the CPHI Japan 2024 exhibition held in Tokyo, Japan from April 17-19, 2024. This annual event, which has been taking place since 2002, has evolved into Japan's largest and most specialized international pharmaceutical exhibition.

Aminowill Shines at CPHI Japan 2024

Japan, being one of the world's largest pharmaceutical markets and ranking second in Asia and third globally, holds approximately 7% of the global market share, following only the United States and China. The significance of this exhibition lies in the immense opportunities it offers to the pharmaceutical industry.

In 2022, the CPHI Japan exhibition attracted more than 550 exhibitors and welcomed over 20,000 professional visitors. Spanning an impressive area of approximately 18,000 square meters, the event showcased a wide range of products and services.

Aminowill, with its expertise in advanced fermentation technology, presented its extensive portfolio of food and pharmaceutical (APIs) grade amino acids at the exhibition. The company's commitment to adhering to strict GMP standards and regulations ensures the absolute purity and highest efficiency of all its products. Aminowill's continuous quality control and quality assurance practices guarantee the delivery of top-notch amino acid solutions.

Visitors to the Aminowill booth had the opportunity to explore a diverse range of products, including amino acid APIs, amino acids for infant formula and nutrition, amino acids for culture media, pharmaceutical intermediates amino acids, and fine chemicals.

The participation of Aminowill in CPHI Japan 2024 further solidified its position as a leading manufacturer of amino acids in China. The company's presence at this prestigious exhibition allowed it to showcase its cutting-edge solutions and contribute to the advancement of the pharmaceutical industry.

Aminowill looks forward to future opportunities to engage with industry professionals and continue its commitment to delivering high-quality amino acids that meet the evolving needs of the global market.

Recommended news